查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1617697

醫療保健分析測試服務市場：按服務、樣本類型、最終用戶分類 - 全球預測 2025-2030

Healthcare Analytical Testing Services Market by Services (Batch Release Testing Services, Bioanalytical Testing, Clinical Trials Testing), Sample Type (Biological Samples, Chemical Substances), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年醫療保健分析實驗室服務市值為48.8億美元，預計到2024年將達到54.1億美元，複合年成長率為11.34%，到2030年將達到103.6億美元。

醫療保健分析測試服務包括各種專業測試服務，這些服務對於確保藥品、生技藥品和醫療設備等醫療保健產品的安全性、有效性和品質至關重要。對這些服務的需求是由嚴格的法規環境推動的，該環境要求進行徹底的測試和驗證，以確保醫療保健產品在進入市場之前符合所需的標準。分析測試服務的應用跨越產品開發的各個階段，從早期研發到臨床試驗以及最終商業化。最終用戶主要包括製藥公司、醫療設備公司、醫療器材製造商和委外研發機構（CRO）。

主要市場統計
基準年[2023] 48.8億美元
預計年份 [2024] 54.1億美元
預測年份 [2030] 103.6億美元
複合年成長率（%） 11.34%

藥品和個人化醫療日益複雜，增加了對先進測試方法的需求，這是調查方法市場的主要驅動力。一個值得注意的成長要素是外包分析測試服務的成長趨勢，使公司能夠專注於其核心能力，同時利用專業服務供應商的專業知識。此外，分析技術的進步以及生物相似藥和生技藥品的廣泛採用也帶來了巨大的成長機會。然而，諸如嚴格的監管合規性、與先進測試技術相關的高成本以及與複雜生技藥品測試相關的技術困難等挑戰仍然是潛在的成長阻礙因素。

自動化高通量測試平台和用於資料分析的人工智慧（AI）的研發是具有巨大業務成長潛力的途徑。隨著行業參與者尋求擴大其全球影響力，投資區域設施並利用當地專業知識是一項推薦策略。市場競爭非常激烈，但差異化服務和策略夥伴關係關係是獲得競爭優勢的途徑。探索精準醫學和生物標記發現測試方面的創新也是可能的。在分析服務中採用永續的綠色化學可以提供更長期的效益，並吸引具有環保意識的相關人員。

市場動態：針對快速發展的醫療保健分析實驗室服務市場揭示的關鍵市場洞察

醫療保健分析測試服務市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 醫療保健領域對分析測試外包的需求不斷成長
    • 生物製藥和醫療設備的持續進步
    • 醫療保健領域公共和私人支出的增加
  • 市場限制因素
    • 缺乏熟練的專業人員
  • 市場機會
    • 融合人工智慧、機器學習等尖端技術
    • 快速檢測方法和個人化醫療方法的開發
  • 市場挑戰
    • 全球嚴格的監管標準

波特五力：引領醫療分析實驗室服務市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解醫療保健分析測試服務市場的外部影響

外部宏觀環境因素在塑造醫療分析實驗室服務市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解醫療保健分析測試服務市場的競爭狀況

醫療保健分析實驗室服務市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣醫療保健分析測試服務市場供應商的績效評估

FPNV 定位矩陣是評估醫療保健分析實驗室服務市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了醫療分析實驗室服務市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對醫療保健分析實驗室服務市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 醫療保健領域對分析測試外包的需求增加
      • 生物製藥和醫療設備的持續進步
      • 醫療保健領域的公共和私人支出增加
    • 抑制因素
      • 高技能專業人才短缺
    • 機會
      • 融合人工智慧、機器學習等先進技術
      • 快速檢測方法和個人化醫療方法的開發
    • 任務
      • 全球嚴格的監管標準
  • 市場區隔分析
    • 服務：醫療保健領域必備的檢測服務，確保藥品品質和環境安全
    • 最終用戶：分析測試在醫療保健和藥物開發中的關鍵作用，確保安全和效率
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章醫療保健分析測試服務市場：依服務分類

  • 大量發布測試服務
  • 生物分析測試
  • 臨床試驗測試
  • 環境監測

第7章按樣本類型分類的醫療保健分析測試服務市場

  • 生物樣本
  • 化學品

第8章醫療保健分析測試服務市場：依最終用戶分類

  • 臨床研究組織
  • 醫療設備公司
  • 製藥和生物製藥公司

第9章美洲醫療保健分析測試服務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太醫療保健分析測試服務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的醫療保健分析測試服務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • LGM Pharma 加強分析測試和製造能力
    • Kindeva Drug Delivery 增強分析服務並擴大藥品和醫療設備的全球能力
    • MilliporeSigma 推出 ChemisTwin，徹底改變生命科學領域的品質測試
  • 戰略分析和建議

公司名單

  • Almac Group Limited
  • ALS Limited
  • Catalent, Inc.
  • CD Biosciences Inc.
  • Charles River Laboratories, Inc.
  • Element Materials Technology Group Limited
  • Eurofins Scientific SE
  • Frontage Laboratories, Inc. by Tigermed
  • ICON PLC
  • Intertek Group PLC
  • IQVIA, Inc.
  • Laboratory Corporation of America Holdings
  • Medpace, Inc.
  • Merck KGaA
  • Pace Analytical Services, LLC
  • Piramal Pharma Solutions
  • PPD, Inc.
  • Reading Scientific Services Ltd.
  • Sartorius AG
  • SGS SA
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec
Product Code: MRR-F949FCDE0EC4

The Healthcare Analytical Testing Services Market was valued at USD 4.88 billion in 2023, expected to reach USD 5.41 billion in 2024, and is projected to grow at a CAGR of 11.34%, to USD 10.36 billion by 2030.

Healthcare Analytical Testing Services encompass a range of specialized laboratory services that are essential for ensuring the safety, efficacy, and quality of healthcare products, including pharmaceuticals, biologics, and medical devices. The necessity of these services stems from the stringent regulatory environment that mandates thorough testing and validation to ensure that healthcare products meet the required standards before reaching the market. The application of analytical testing services spans various stages of product development, from early research and development to clinical trials, and ultimately to commercialization. End-users primarily include pharmaceutical and biopharmaceutical companies, medical device manufacturers, and contract research organizations (CROs).

KEY MARKET STATISTICS
Base Year [2023] USD 4.88 billion
Estimated Year [2024] USD 5.41 billion
Forecast Year [2030] USD 10.36 billion
CAGR (%) 11.34%

The market for healthcare analytical testing services is being significantly driven by the increasing complexity of pharmaceutical products and personalized medicine, which necessitate sophisticated testing methodologies. A notable growth driver is the rising trend in outsourcing analytical testing services, which enables companies to focus on their core competencies while leveraging the expertise of specialized service providers. Additionally, advancements in analytical technologies and the increasing adoption of biosimilars and biologics provide substantial growth opportunities. However, challenges such as strict regulatory compliance, high costs associated with advanced testing techniques, and technical difficulties related to complex biologics testing remain potential growth deterrents.

Innovation and research in the development of automated and high-throughput testing platforms, and artificial intelligence (AI) for data analysis are avenues with immense potential for business growth. As industry players look toward expanding their global presence, investment in regional facilities and leveraging local expertise are recommended strategies. Despite the competitive nature of the market, differentiated service offerings and strategic partnerships provide avenues for competitive advantage. Companies could also explore innovation in precision medicine and biomarker discovery testing, as these areas are set to see burgeoning demand. Adopting sustainable and green chemistry practices in analytical services can further yield long-term benefits and appeal to environmentally-conscious stakeholders.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Healthcare Analytical Testing Services Market

The Healthcare Analytical Testing Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for analytical testing outsourcing in healthcare sector
    • Ongoing advances in biopharmaceuticals and medical devices
    • Rising public and private expenditure in healthcare sector
  • Market Restraints
    • Lack of highly skilled professionals
  • Market Opportunities
    • Integration of advanced technologies including AI and machine learning
    • Development of rapid testing methods and personalized medicine approach
  • Market Challenges
    • Stringent regulatory standards worldwide

Porter's Five Forces: A Strategic Tool for Navigating the Healthcare Analytical Testing Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Healthcare Analytical Testing Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Healthcare Analytical Testing Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Healthcare Analytical Testing Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Healthcare Analytical Testing Services Market

A detailed market share analysis in the Healthcare Analytical Testing Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Healthcare Analytical Testing Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Healthcare Analytical Testing Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Healthcare Analytical Testing Services Market

A strategic analysis of the Healthcare Analytical Testing Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Healthcare Analytical Testing Services Market, highlighting leading vendors and their innovative profiles. These include Almac Group Limited, ALS Limited, Catalent, Inc., CD Biosciences Inc., Charles River Laboratories, Inc., Element Materials Technology Group Limited, Eurofins Scientific SE, Frontage Laboratories, Inc. by Tigermed, ICON PLC, Intertek Group PLC, IQVIA, Inc., Laboratory Corporation of America Holdings, Medpace, Inc., Merck KGaA, Pace Analytical Services, LLC, Piramal Pharma Solutions, PPD, Inc., Reading Scientific Services Ltd., Sartorius AG, SGS SA, Thermo Fisher Scientific Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Healthcare Analytical Testing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Batch Release Testing Services, Bioanalytical Testing, Clinical Trials Testing, and Environmental Monitoring.
  • Based on Sample Type, market is studied across Biological Samples and Chemical Substances.
  • Based on End User, market is studied across Clinical Research Organizations, Medical Device Companies, and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for analytical testing outsourcing in healthcare sector
      • 5.1.1.2. Ongoing advances in biopharmaceuticals and medical devices
      • 5.1.1.3. Rising public and private expenditure in healthcare sector
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of highly skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies including AI and machine learning
      • 5.1.3.2. Development of rapid testing methods and personalized medicine approach
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory standards worldwide
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Essential Testing Services in Healthcare Sector, Safeguarding Drug Quality and Environmental Safety
    • 5.2.2. End User: Crucial Role of Analytical Testing in Healthcare and Pharmaceutical Development, Ensuring Safety and Efficiency
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Healthcare Analytical Testing Services Market, by Services

  • 6.1. Introduction
  • 6.2. Batch Release Testing Services
  • 6.3. Bioanalytical Testing
  • 6.4. Clinical Trials Testing
  • 6.5. Environmental Monitoring

7. Healthcare Analytical Testing Services Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Biological Samples
  • 7.3. Chemical Substances

8. Healthcare Analytical Testing Services Market, by End User

  • 8.1. Introduction
  • 8.2. Clinical Research Organizations
  • 8.3. Medical Device Companies
  • 8.4. Pharmaceutical & Biopharmaceutical Companies

9. Americas Healthcare Analytical Testing Services Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Healthcare Analytical Testing Services Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Healthcare Analytical Testing Services Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Enhancing Analytical Testing and Manufacturing Capabilities by LGM Pharma
    • 12.3.2. Kindeva Drug Delivery Bolsters Analytical Services, Enhancing Global Capabilities in Pharmaceutical and Medical Device Sectors
    • 12.3.3. Launch of ChemisTwin by MilliporeSigma, Revolutionizing Quality Testing in Life Sciences
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Almac Group Limited
  • 2. ALS Limited
  • 3. Catalent, Inc.
  • 4. CD Biosciences Inc.
  • 5. Charles River Laboratories, Inc.
  • 6. Element Materials Technology Group Limited
  • 7. Eurofins Scientific SE
  • 8. Frontage Laboratories, Inc. by Tigermed
  • 9. ICON PLC
  • 10. Intertek Group PLC
  • 11. IQVIA, Inc.
  • 12. Laboratory Corporation of America Holdings
  • 13. Medpace, Inc.
  • 14. Merck KGaA
  • 15. Pace Analytical Services, LLC
  • 16. Piramal Pharma Solutions
  • 17. PPD, Inc.
  • 18. Reading Scientific Services Ltd.
  • 19. Sartorius AG
  • 20. SGS SA
  • 21. Thermo Fisher Scientific Inc.
  • 22. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BATCH RELEASE TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL TRIALS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOLOGICAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHEMICAL SUBSTANCES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023